Vitalant

Vitalant: 7 recalls listed since June 2026 across FDA; 7 ended.

By year

Red Blood Cells, Leukocytes Reduced were distributed from a donor with travel history to a malaria endemic area but not assessed for residency.

Moderate riskFDASep 21, 2026Blood donor screening

Pooled Cryoprecipitated AHF was not prepared in accordance with specifications.

Moderate riskFDASep 2, 2026Quality testing problem

Apheresis Platelets, Leukocytes Reduced were distributed with platelet yield that did not meet specifications.

Moderate riskFDAAug 28, 2026Quality testing problem

Apheresis Platelets, Leukocytes Reduced, Irradiated were labeled as leukocytes reduced but were not tested to verify white blood cell count.

Moderate riskFDAJul 7, 2026Quality testing problem

Apheresis Red Blood Cells, Leukocytes Reduced were collected with a potential for air contamination.

Moderate riskFDAJun 30, 2026Contamination

Apheresis Platelets, Leukocytes Reduced, Irradiated had a platelet count higher than acceptable.

Moderate riskFDAJun 30, 2026Quality testing problem

Apheresis Platelets, Leukocytes Reduced had platelet yield that did not meet specifications.

Moderate riskFDAJun 24, 2026Quality testing problem